MediPharm Labs Corp.
MEDIF
$0.057
$0.00611.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.74% | 29.52% | -22.90% | 32.44% | -50.42% |
| Total Depreciation and Amortization | -28.90% | -8.84% | 11.20% | 14.57% | -10.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.50% | 5.47% | 153.41% | -76.37% | 78.66% |
| Change in Net Operating Assets | 253.19% | -207.30% | -89.70% | 295.79% | 183.77% |
| Cash from Operations | 58.64% | -3.69% | -204.48% | 144.96% | 57.01% |
| Capital Expenditure | 40.83% | -162.18% | 82.17% | 54.85% | -288.38% |
| Sale of Property, Plant, and Equipment | -- | -96.22% | 209.63% | -90.78% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 5.47% | -106.57% | -87.70% | 158.51% | 73.94% |
| Total Debt Issued | -93.32% | -- | -- | -- | -- |
| Total Debt Repaid | -1,398.04% | 43.12% | 31.20% | -0.77% | 52.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.53% | -56.16% | 35.33% | 68.54% | -89.42% |
| Cash from Financing | -425.43% | 1,121.63% | 72.33% | 20.55% | -127.45% |
| Foreign Exchange rate Adjustments | -13.73% | 71.91% | 102.37% | -623.60% | 13.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -211.06% | 12.68% | -121.16% | 376.79% | 66.81% |
